# FDA Inspection 1117923 - Solaris Pharma Corp - January 09, 2020

Source: https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/84366ff4-2f07-49eb-89c5-e3009928fbd2
Source feed: FDA_Inspections

> FDA Inspection 1117923 for Solaris Pharma Corp on January 09, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117923
- Company Name: Solaris Pharma Corp
- Inspection Date: 2020-01-09
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/21c2d32d-4377-4be5-8382-b321a855a9ae)
- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/a78a33e0-bed5-43f4-8243-b3dddf80fd56)

Company: https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c